Introduction
The family Elapidae consists of a variety of highly venomous snake genera, including the death adders (Acanthophis spp.), which are considered elapids despite their viperlike appearance and behaviour. In addition, death adders have semi-mobile fangs which results in them being commonly regarded as the most evolved of all elapids and morphologically transitional between the Elapidae and Viperidae. Indeed, death adders are the widest ranging of the Australian elapids with a variety of species found throughout continental Australia, Irian Jaya, Papua New Guinea (PNG) and some eastern Indonesian islands including the Maluku islands of Seram (formerly Ceram), Halmahera, Obi and Tanimbar (Lalloo et al., 1996; Wüster et al., 2005) . This wide range and ecological specialization of Acanthophis is consistent with its relatively early divergence from its closest sister lineage around 9.1 Mya (Sanders et al., 2008) .
Acanthophis species are the second most common cause of envenomation in the Central Province and National Capital District of PNG, second only to the Papuan taipan (Oxyuranus scutellatus canni). They have been reported to be responsible for ca. 11% of patients admitted for envenomation in these areas between January 1990 and June 1992 (Lalloo et al., 1994) . The death adder has additionally been reported to be the cause of most serious envenomations in the Madang region of PNG (Hudson and Pomat, 1988) while in northern Australia death adder envenomation is also considered a serious problem (Currie, 2003) . General symptoms of envenomation from Acanthophis species can include pain in regional lymph nodes, and non-specific systemic features such as abdominal pain, headache, drowsiness, nausea and vomiting. More problematic are neurological symptoms that typically involve ptosis, dysarthria, dysphagia, diplopia and flaccid muscle paralysis with death resulting from respiratory failure (Campbell, 1966; Lalloo et al., 1996) . Myotoxicity is not usually associated with envenomation but there are clinical reports in PNG of rhabdomyolysis with A. rugosus (Lalloo et al., 1996) . Significantly, delayed-onset neurotoxicity is a problem in death adder envenomations, occasionally with late presentation of neurotoxicity as the first feature of envenoming (Currie, 1989; Currie, 2003; Lalloo et al., 1996) . This has resulted in a recommended hospital admission period of 24 hours for B. Blacklow et al. / Toxicon 5 patients in PNG and both central and northern Australia, and for children in any region (Currie, 2006) .
The primary treatment for death adder envenomation is CSL monovalent death adder antivenom, which has been raised against A. antarcticus (White, 1998; White, 2001 ).
Death adder antivenom appears to be quite effective in preventing the progression of neurotoxicity from all species of death adder in Australia and PNG (Campbell, 1966; Lalloo et al., 1996) , showing a rapid reversal of paralysis. However, conflicting reports with Australian death adder envenomation have suggested that the neurotoxic effects can be poorly reversed by antivenom or anticholinesterase (neostigmine) if the patient presents late after envenomation (Gunja et al., 2007) . In support, an in vitro study involving A. antarcticus, A. praelongus and A. pyrrhus venoms found that all three venoms produced rapid postsynaptic neurotoxicity but antivenom displayed varying efficacy to reverse toxicity following neuromuscular blockade over a 4 hour period.
Indeed, there was only a 22% recovery of contractile responses following complete neuromuscular blockade with A. antarcticus, the venom to which the antivenom is raised .
It is commonly regarded that death adder neurotoxicity is mainly postsynaptic in origin, and therefore this suggests that the postsynaptic neurotoxins (so-called 'α-' or 'threefingered' neurotoxins) present within death adder venoms may not be completely reversible or are 'pseudo-irreversible'. However, rapidly developing neurotoxicity from postsynaptic neurotoxins conceals the action of any underlying presynaptic neurotoxins or myotoxins that may be present in the venom, which typically have slower onsets of activity but bind irreversibly (Kelly and Brown, 1974; Wilson et al., 1995) . In the case of patients with delayed-onset or slowly-developing neurotoxicity, presynaptic neurotoxins or myotoxins may play a significant role in the speed of recovery following antivenom therapy due to the irreversible nature of their actions, and may go some way to explain the above resistance to antivenom therapy. The presence of myotoxins in the venom of . praelongus, A. rugosus, A. sp. Seram, and A. wellsi species has been previously determined (Hart et al., 2005; Wickramaratna et al., 2003a; Wickramaratna et al., 2003b ) and rhabdomyolysis has been reported clinically with A. rugosus envenomation B. Blacklow et al. / Toxicon 6 (Lalloo et al., 1996) . However, this does not exclude the presence of presynaptic neurotoxins in these venoms, or in other major species or geographic variants of A.
A

antarcticus.
It is therefore possible that Acanthophis venoms contain snake presynaptic phospholipase A 2 (PLA 2 ) neurotoxins (so-called 'β-neurotoxins' or SPANs) that bind irreversibly to motor nerve terminals (Rossetto and Montecucco, 2008) . In support, highly toxic heteromultimeric SPANs have been identified and pharmacologically characterized from the venom of a number of other Australo-Papuan elapid snake venoms, including, paradoxin (inland taipan, Oxyuranus microlepidotus; (Fohlman, 1979; Hodgson et al., 2007) , taipoxin (coastal taipan, O. scutellatus; , cannitoxin (Papuan taipan, O. scutellatus canni; (Kuruppu et al., 2005b) and textilotoxin (common brown snake, Pseudonaja textilis; (Su et al., 1983; Wilson et al., 1995) and the monomeric notexin (tiger snake, Notechis s. scutatus; (Cull-Candy et al., 1976) . These are potent presynaptically-active neurotoxins with an LD 50 of 1-25 µg/kg (mouse i.v. or i.p.). Furthermore, a protein from A. antarcticus venom with significant Nterminal sequence homology to the γ-chain of the heterotrimeric SPAN taipoxin has been previously reported (Fry et al., 2002) , suggestive of the presence of a SPAN in Acanthophis venom.
SPANs can cause irreversible neurotoxicity via the depletion of neurotransmitter, due to a modest increase in transmitter release and a block of vesicle recycling, as well as the degeneration of motor nerve terminals and intramuscular axons (Harris et al., 2000) .
Regeneration and functional reinnervation can take several days (Dixon and Harris, 1999; Harris et al., 2000) and in humans paralysis resulting from SPANs not promptly treated with antivenom can last many days. Some patients even require artificial ventilation and, in isolated cases, intensive care for prolonged periods (Connolly et al., 1995; Pearn, 1971; Trevett et al., 1995) . While a number of monomeric PLA 2 proteins have been isolated from death adder venom (Chow et al., 1998; Sim, 1998; van der Weyden et al., 2000; van der Weyden et al., 1997) , none of these have been characterized pharmacologically and there have be no previous reports of attempts at isolating multimeric SPAN complexes in the venom of Acanthophis spp.
B. Blacklow et al. / Toxicon 7 Given the high potency of SPAN complexes from other Australian elapid venoms, the aim of this study was to determine whether the venoms of various species and geographic variants of Australian death adders also contain SPAN complexes. The presence of such components could explain reports of poorly reversible neurotoxicity in post-envenomated patients not treated promptly with antivenom.
Materials and methods
Venom source and storage
Lyophilized pooled Acanthophis spp. venoms were provided by Venom Supplies (Tanunda, South Australia). The death adders were collected from their natural habitats in Australia and PNG. A degree of controversy exists regarding the taxonomy of the death adders (Williams et al., 2006; Wüster et al., 2005; Wüster et al., 1999) , with as many as 15 separate species reported by various sources. Therefore, reporting the locations of Acanthophis snakes used in this study is crucial to allow any subsequent interpretation of these results in the light of any future revision of the taxonomy of (Wüster et al., 2005) . This study will (Chippaux et al., 1991) . Venoms were collected from fang tips through the specimen biting down on a parafilm covered specimen bottle and injecting the venom into a polyethylene container, in combination with the use of polyethylene pipette tip to milk any residual venom from the fang. The venoms were then lyophilised and stored at -20°C until required.
Size-exclusion FPLC under non-denaturing conditions
Bioassay-guided isolation of toxins from whole venom was performed using a Shimadzu CLASS-VP HPLC system. Prior to separation, samples were suspended in equilibration buffer and centrifuged at 10,000 rpm for 5 min, with the resulting supernatant (equivalent to ca. 3 mg of venom) applied to a Superdex G-75 column (10 x 300 mm, 13 µm; GE Healthcare, Sydney, NSW, Australia) equilibrated with ammonium acetate (0.1 M, pH 6.8). Fractions were eluted using an isocratic gradient at a flow rate of 0.75 ml/min. Elution profiles were monitored at 280 and 214 nm, however only the profile obtained at 280 nm is shown. Resulting fractions were screened for both neurotoxic and myotoxic activity using the chick biventer cervicis nerve-muscle (CBCNM) preparation (see section 2.4) and phospholipase A 2 (PLA 2 ) activity (see section 2.5). The approximate molecular mass of any SPAN complex was determined by gel filtration under non-reducing conditions on the Superdex G-75 column equilibrated with ammonium acetate buffer (0.1 M; pH 6.8). The column was calibrated with the series of known standards (6.5-66 kDa) using the molecular mass marker kit for gel filtration chromatography (lot no. 093K9307; MWGF-70; Sigma-Aldrich, St. Louis, MO) at a flow rate of 0.75 ml/min. The void volume (V o ) of the column was determined by running blue dextran (2,000 kDa), and the elution volume (V e ) was calculated for each molecular mass marker. The molecular mass range of SPAN complexes were then determined from interpolation of a plot of log molecular mass versus retention ratio (V e / V o ) of the standards.
B. Blacklow et al. / Toxicon
Bicinchoninic Acid Protein (BCA) Assay:
Following lyophilisation, the protein concentrations of purified high molecular mass fractions were determined using the Quantipro™ BCA assay kit (Sigma-Aldrich). Protein contents between 5-200 µg/ml were detected at 560 nm by a Titertek Multiscan Plus MKII (type 313) plate reader (Flow Laboratories Australasia, North Ryde, NSW). A standard curve was created using bovine serum albumin from which protein concentrations of the venom fractions were interpolated. Yields of the high molecular mass fraction (22 to >66 kDa) were then expressed as a percentage of whole venom loaded onto the column (3 mg).
Isolated chick biventer cervicis nerve-muscle preparation
Isolated fractions were tested for neurotoxic and myotoxic activity using the isolated CBCNM preparation (Ginsborg and Warriner, 1960 (Harvey et al., 1994) . After each agonist incubation period, washout was repeated until a stable baseline was observed. Following addition of SPAN (10 µg/ml), twitch tension amplitude was monitored for 4 hours, or until twitches were abolished.
Time-matched controls confirmed that muscle fatigue was not significant up to 4 hours after introduction of muscles into the organ bath. Muscle tension from isometric force transducers was amplified using a ML221 bridge amplifier (ADInstruments) and recorded using a Powerlab 2/25 system (ADInstruments) connected to an iMac or PC computer. Data was digitised at 140 Hz and filtered using 50/60 Hz high-pass and 20-200 Hz low-pass filters. Muscle tension was recorded using Chart v5.5.4 software (ADInstruments).
Phospholipase A 2 (PLA 2 ) activity assay
The PLA 2 activity of whole venoms and isolated toxins were determined using a LaserBio Labs, France) using the same matrix system. Spectra were processed using the Data Explorer software package (Applied Biosystems).
Chemicals and drugs
Unless otherwise stated, all chemicals and drugs were purchased from Sigma-Aldrich, Castle Hill, NSW, Australia. 
Data analysis
Results
Venom fractionation
Separation of Acanthophis spp. whole venoms by size-exclusion FPLC under nonreducing conditions produced a characteristic pattern of fractions from all death adder
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12 venom samples (Fig. 1) . In general, resultant chromatograms displayed 4-6 major peaks. Nevertheless, variation in chromatographic profiles was evident between the regional variants of A. antarcticus as well as other Acanthophis spp., where the variation was more pronounced. Given that SPAN complexes have molecular masss ranging between 21 kDa (the covalently-linked heterodimer β-bungarotoxin from Bungarus fasciatus; (Chu et al., 1995) and ca. 87 kDa (the heterohexameric textilotoxin; (Aquilina, 2009 ) fractions falling into this molecular mass range were collected for neurotoxicity testing. Following calibration of the size-exclusion column using a set of molecular mass markers, the retention times of early-eluting fractions were found to be consistent with a molecular mass range between 22 kDa to >66 kDa (shaded fractions in Fig. 1Aa and B) .
Given that the calibration of the size-exclusion Sephadex G-75 column may not be linear beyond 66 kDa (bovine serum albumin was the highest mass standard used), we have elected not to extrapolate beyond this upper limit. Importantly, separation of A.
wellsi and A. pyrrhus venoms did not result in any early-eluting components (Fig. 1Ab) and therefore these venoms were not investigated any further in this study. For the remaining venoms, the yields of this high molecular mass fraction, as determined by the BCA assay, appear to vary significantly, with A. laevis possessing the highest yield of 14.9% w/w while A. antarcticus (SA) had the lowest yield of 2.7% w/w. The percent yields of the prejunctional neurotoxin component from each Acanthophis venom are shown in Table 1 .
Neurotoxicity studies
Apart from A. antarcticus (SA) venom, all high molecular mass fractions produced timedependant inhibition of nerve-evoked twitch contractions within 240 min (n = 3-4; Fig.   2A ), whereas with time-matched controls there was no significant inhibition of twitch tension over the 240 min period (Fig. 2B) . The mean t 90 values ranged from 59 to 85 min (see Table 1 ). There was no significant difference between high molecular mass fractions from all venoms except that from A. antarcticus (SA) venom, which failed to reach 90% block after 240 min. Because experiments were terminated after 240 min, the t 90 value for the high molecular mass fraction from A. antarcticus (SA) venom was (Su and Chang, 1984; Wilson et al., 1995) . The remaining Acanthophis spp. venom fractions did not overtly display this triphasic timecourse, consistent with that often seen for SPANs in avian neuromuscular preparations (Beghini et al., 2004; Kuruppu et al., 2005b) .
Importantly, following complete neuromuscular blockade by all high molecular mass fractions, responses to cholinergic agonists were still present whereas the negative control had no significant inhibitory effect on the contractures produced by exogenous agonists (n = 3-4; Fig. 3 ). While A. laevis caused the only statistically significant inhibition of ACh responses (one-way ANOVA, p < 0.01, n = 3), contractures were not completely abolished. Moreover, the responses to carbachol were not significantly inhibited by any high molecular mass fraction (one-way ANOVA, p > 0.05, n = 3-4).
Interestingly, the responses to carbachol were enhanced in controls and venom fractions but this has been previously reported in this preparation (Kuruppu et al., 2005a; Kuruppu et al., 2005b; Lumsden et al., 2005) and may reflect time-dependent sensitization of the tissue to carbachol. All fractions failed to significantly inhibit responses to potassium chloride (one-way ANOVA, p > 0.05, n = 3-4) and did not cause a significant change in the baseline tension of the biventer cervicis muscle (data not shown). These actions are consistent with the presence of SPAN complexes in the high molecular mass fraction that inhibit neurotransmitter release.
PLA 2 activity
The PLA 2 activity of whole venoms and isolated prejunctional neurotoxic components showed some variability (Fig. 3) . Whole venoms and isolated components all possessed PLA 2 activity, however the individual activities were much lower than the positive control (bee venom), which had a PLA 2 activity of 181.8 ± 9.7 µmol/min/mg. PLA 2 activity of the 
Mass spectrometry
Given that there was considerable variation in the neurotoxicity of the regional variants of A. antarcticus, the mass profile of NSW, QLD and SA geographic variants of A.
antarcticus venoms were examined. The MALDI-TOF mass spectra of these venoms were dominated by high-intensity ions at ca. 6400-6700, 6700-7100, 7200-8900 and 12800-14000 m/z ranges (Fig. 5) . This is consistent with the presence of Kunitz-type protease inhibitors, short-chain α-neurotoxins, long-chain α-neurotoxins and monomeric PLA 2 neurotoxins, respectively. Allowing for minor measurement differences resulting from external calibration, it appears that these venoms contain a number of equivalent 
Discussion
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Excluding the venoms of A. wellsi and A. pyrrhus, all species including the geographic variants of death adder venoms contained early eluting fractions with masses estimated between 22 and >66 kDa. Apart from A. antarcticus (SA), each of these high molecular mass fractions caused a block of muscle contractility consistent with strong prejunctional neurotoxicity. Each of these components also possessed significant PLA 2 enzymatic activity. Given that these components represent a significant portion of the whole venom, they would therefore contribute to the overall toxicity of the venom. The estimated size, neurotoxicity and PLA 2 enzymatic activity indicates that these isolated venom components most likely contain SPANs that are likely composed of a multimeric structure. It is interesting to speculate therefore that these SPANs have a similar heterotrimeric complex of ca. 45 kDa much like previously isolated SPANs such as taipoxin, cannitoxin and paradoxin from various species of Oxyuranus (Fohlman, 1979; Fohlman et al., 1976; Kuruppu et al., 2005b) . A number of components with molecular masses comparable to other snake monomeric PLA 2 neurotoxins and inhibitors of platelet aggregation (ca. 12.8-14 kDa) were conserved in venoms from NSW, QLD and SA geographic variants of A. antarcticus. It is therefore surprising that A. antarcticus (SA) venom, which possessed only a weakly active high molecular mass fraction, contained all five of these proteins. This suggests that other components in this mass range form the subunits of the SPAN complex. While there exists the possibility that this fraction could contain blockers of voltage-gated sodium or calcium channels to inhibit neurotransmission, the high mass and PLA 2 activity consistent with other SPANs would argue against this. Further biochemical studies of several of these venoms is presently being undertaken to ascertain the subunit structure and confirm the pharmacological basis for this prejunctional neurotoxicity (unpublished data).
Of note is the absence of a high molecular mass SPAN complex in the venoms of A.
wellsi and A. pyrrhus. These two well-differentiated species are believed to belong to a separate clade distinct from other species of Acanthophis (Wüster et al., 2005) , supporting their unique size-exclusion chromatographic profile. Importantly, these two venoms appear to have a higher yield of monomeric PLA 2 neurotoxins (ca. 12.8-14 kDa) and/or postsynaptic α-neurotoxins (ca. 6.7-8.9 kDa) based on the molecular mass of the large eluting peak between 17 and 22 min (Fig. 1Ab) .
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Notably there was an apparent lack of any overt myotoxicity in the high molecular mass fraction of all venoms, as evidenced by a lack of inhibition of KCl responses and the absence of any change in baseline tension in the CBCNM preparation. This would suggest that previously identified myotoxins from A. rugosus (Wickramaratna et al., 2003a) and A. sp. Seram (A. laevis in this study; (Hart et al., 2005) appear to exist as monomeric PLA 2 myotoxins (13082-13896 Da), eluting later in the size-exclusion chromatogram rather than as a complex of higher molecular mass. Thus none of the high molecular mass SPAN complexes in Acanthophis venoms appear to possess significant myotoxic activity, as has been described for the 45 kDa heterotrimeric SPAN, taipoxin (Harris et al., 2000; Harris and Maltin, 1982) .
The poor reversibility of Acanthophis neurotoxicity particularly A. antarcticus, both in vitro ) and clinically (Gunja et al., 2007) , could be the result of irreversible binding of long-chain snake α-neurotoxins. In support, longchain snake α-neurotoxins such as Aa b (8125 Da, (Kim and Tamiya, 1981) , Aa e (8751 Da, (Tyler et al., 1997) , acanthophin d (8377 Da, (Sheumack et al., 1990) , and α- were identified in the MALDI-TOF mass profiles in Figure 5 . In summary, the present study has identified the presence of SPANs in at least six, of the nine, venoms investigated. If long-chain snake α-neurotoxins were also present in any of these other venoms they should only serve to increase the poor reversibility of neurotoxicity seen with inadequate use of antivenom.
Reduction in the ACh response by the high molecular mass fraction of A. laevis venom could be due to the presence of postsynaptic PLA 2 complexes such as has been described for vipoxin a 27.5 kDa heterodimeric PLA 2 complex from the Bulgarian viper (Vipera ammodytes meridionalis) (Banumathi et al., 2001 ). On the hand, the reduction in ACh response could also be due to the presence of an acetylcholinesterase in the high molecular mass fraction in amounts sufficient to hydrolyse exogenous acetylcholine. Acetylcholinesterase has been characterized previously from Bungarus fasciatus venom (Cousin et al., 1996) and matched to several 70-kDa proteins in the venoms of several Australian elapids, including A. antarcticus, in a recent proteomic study (Birrell et al., 2007) . However, neither of these possibilities is likely given that responses to carbachol, a nicotinic agonist resistant to the actions of acetylcholinesterase, were not significantly inhibited at complete neuromuscular blockade.
The effectiveness of prior administration of antivenom (5 U/ml) to completely neutralize the in vitro neurotoxicity of venom from all major species and geographic variants of Acanthophis has been previously confirmed (Fry et al., 2001) . Therefore, considering the present findings that the majority of death adder venoms contain SPANs, early intervention with antivenom is critically important in preventing severe prolonged envenomation. The results of the present study indicate that clinicians may need to be aware of possible prejunctional neurotoxicity following envenomation from A. antarcticus (all geographic variants except SA), A. praelongus, A. rugosus, or A. laevis species.
Unfortunately, there are no current treatments that prevent the destruction of the nerve terminal once the process of degeneration has been initiated, enhance the repair of the structural damage to the peripheral innervation or increase the rate at which the victims recover neuromuscular function. This would suggest that early antivenom intervention is essential to preventing the further development of toxicity caused by these snakes. 
